Redmile Group, LLC Repare Therapeutics Inc. Transaction History

Redmile Group, LLC

  • $908 Million
  • Q3 2025

A detailed history of Redmile Group, LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 1,586,174 shares of RPTX stock, worth $2.62 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
1,586,174
Previous 1,586,174 -0.0%
Holding current value
$2.62 Million
Previous $2.2 Million 26.63%
% of portfolio
0.31%
Previous 0.27%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$0.9 - $1.49 $268,393 - $444,340
-298,215 Reduced 15.83%
1,586,174 $2.2 Million
Q1 2025

May 15, 2025
SELL
$0.99 - $1.39 $31,383 - $44,063
-31,700 Reduced 1.65%
1,884,389 $1.87 Million
Q4 2024

Feb 14, 2025
SELL
$1.25 - $3.97 $33,082 - $105,070
-26,466 Reduced 1.36%
1,916,089 $2.51 Million
Q2 2024

Aug 14, 2024
SELL
$3.02 - $4.7 $222,715 - $346,610
-73,747 Reduced 3.66%
1,942,555 $6.41 Million
Q1 2024

May 15, 2024
SELL
$4.53 - $8.41 $599,980 - $1.11 Million
-132,446 Reduced 6.16%
2,016,302 $9.5 Million
Q4 2023

Feb 14, 2024
SELL
$3.22 - $11.79 $900,270 - $3.3 Million
-279,587 Reduced 11.51%
2,148,748 $15.7 Million
Q2 2023

Aug 14, 2023
SELL
$8.63 - $12.53 $903,690 - $1.31 Million
-104,715 Reduced 4.13%
2,428,335 $25.7 Million
Q1 2023

May 15, 2023
SELL
$9.32 - $15.06 $1.41 Million - $2.28 Million
-151,346 Reduced 5.64%
2,533,050 $24.9 Million
Q3 2022

Nov 14, 2022
SELL
$11.57 - $15.59 $423,462 - $570,594
-36,600 Reduced 1.35%
2,684,396 $32.6 Million
Q2 2022

Aug 15, 2022
SELL
$8.45 - $14.84 $101,399 - $178,080
-12,000 Reduced 0.44%
2,720,996 $38.1 Million
Q1 2022

May 16, 2022
SELL
$11.38 - $21.88 $642,970 - $1.24 Million
-56,500 Reduced 2.03%
2,732,996 $38.9 Million
Q4 2021

Feb 14, 2022
BUY
$19.66 - $28.11 $4.36 Million - $6.23 Million
221,800 Added 8.64%
2,789,496 $58.8 Million
Q3 2021

Nov 15, 2021
SELL
$25.71 - $35.24 $1.46 Million - $2 Million
-56,700 Reduced 2.16%
2,567,696 $67.4 Million
Q2 2021

Aug 16, 2021
SELL
$30.1 - $34.85 $1.24 Million - $1.43 Million
-41,100 Reduced 1.54%
2,624,396 $81.8 Million
Q1 2021

May 17, 2021
BUY
$25.89 - $44.46 $460,842 - $791,388
17,800 Added 0.67%
2,665,496 $81.8 Million
Q4 2020

Feb 16, 2021
BUY
$23.42 - $39.5 $5.68 Million - $9.59 Million
242,722 Added 10.09%
2,647,696 $90.8 Million
Q3 2020

Nov 16, 2020
BUY
$21.55 - $33.92 $405,140 - $637,696
18,800 Added 0.79%
2,404,974 $74 Million
Q2 2020

Aug 14, 2020
BUY
$30.8 - $32.99 $73.5 Million - $78.7 Million
2,386,174 New
2,386,174 $74 Million

Others Institutions Holding RPTX

# of Institutions
50
Shares Held
30.3M
Call Options Held
158K
Put Options Held
0
View Full List

About Repare Therapeutics Inc.

RPTX Quotes by TradingView
  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $69.2M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email